Related references
Note: Only part of the references are listed.Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era
Antonio Ceriello et al.
DIABETES CARE (2020)
The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan
Yang Zhang et al.
DIABETES OBESITY & METABOLISM (2020)
Why is hyperglycaemia worseningCOVID-19 and its prognosis?
Antonio Ceriello et al.
DIABETES OBESITY & METABOLISM (2020)
The diabetic lung: An easy target forSARS-CoV-2?
Irene Caruso et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2020)
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
Bertrand Cariou et al.
DIABETOLOGIA (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time ofCOVID-19 pandemic
Marco Infante et al.
JOURNAL OF DIABETES (2020)
Prevalence and impact of diabetes among people infected with SARS-CoV-2
G. P. Fadini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
COVID-19 and diabetes from IDF MENA region
Jamal Belkhadir
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Hyperglycaemia on admission to hospital and COVID-19
Celestino Sardu et al.
DIABETOLOGIA (2020)
DIABETES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM: IMPLICATIONS FOR COVID-19 PATIENTS WITH DIABETES TREATMENT MANAGEMENT
Doina Catrinoiu et al.
FARMACIA (2020)
The Enigma of Endothelium in COVID-19
Savneet Kaur et al.
FRONTIERS IN PHYSIOLOGY (2020)
Vitamin D for COVID-19: a case to answer?
Adrian R. Martineau et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights
Anca Pantea Stoian et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2020)
COVID-19: A Lever for the Recognition of Obesity as a Disease? The French Experience
Karine Clement et al.
OBESITY (2020)
COVID-19 in people living with diabetes: An international consensus
A. E. Caballero et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors
Alexandros Sachinidis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
Ashish Kumar et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
Bruce Bode et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)
COVID-19 Specialized Diabetes Clinic model for excellence in diabetes care: scientific perspective
Ahmed M. El-Malky et al.
CLINICAL DIABETOLOGY (2020)
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology
M. Puig-Domingo et al.
ENDOCRINE (2020)
Hypoglycemia at the time of Covid-19 pandemic
Kiran Shah et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
The epidemiology of obesity
Yu Chung Chooi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
R. E. Ratner et al.
DIABETES OBESITY & METABOLISM (2013)
Share Paper
